192 related articles for article (PubMed ID: 33369017)
1. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study.
Baxter JD; Dunn D; Tostevin A; Marvig RL; Bennedbaek M; Cozzi-Lepri A; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J;
HIV Med; 2021 May; 22(5):360-371. PubMed ID: 33369017
[TBL] [Abstract][Full Text] [Related]
2. Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.
Pimentel V; Pingarilho M; Sebastião CS; Miranda M; Gonçalves F; Cabanas J; Costa I; Diogo I; Fernandes S; Costa O; Corte-Real R; Martins MRO; Seabra SG; Abecasis AB; Gomes P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675962
[TBL] [Abstract][Full Text] [Related]
3. Added Value of Next Generation over Sanger Sequencing in Kenyan Youth with Extensive HIV-1 Drug Resistance.
Novitsky V; Nyandiko W; Vreeman R; DeLong AK; Manne A; Scanlon M; Ngeresa A; Aluoch J; Sang F; Ashimosi C; Jepkemboi E; Orido M; Hogan JW; Kantor R;
Microbiol Spectr; 2022 Dec; 10(6):e0345422. PubMed ID: 36445146
[TBL] [Abstract][Full Text] [Related]
4. Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.
Cozzi-Lepri A; Dunn D; Tostevin A; Marvig RL; Bennedbaek M; Sharma S; Kozal MJ; Gompels M; Pinto AN; Lundgren J; Baxter JD;
HIV Med; 2024 Feb; 25(2):212-222. PubMed ID: 37775947
[TBL] [Abstract][Full Text] [Related]
5. Comparison of an
Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
Ouyang F; Yuan D; Zhai W; Liu S; Zhou Y; Yang H
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400015
[TBL] [Abstract][Full Text] [Related]
7. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Transmitted Drug Resistance among HIV-1 Patients in the Aegean Region: Results from the Western Part of Turkey.
Sertoz R; Tekin D; Erensoy S; Biceroglu S; Kaptan F; Köse S; Ozkan H; Cetin B; Türken M; Gokengin D
Curr HIV Res; 2023; 21(2):109-116. PubMed ID: 37231747
[TBL] [Abstract][Full Text] [Related]
9. Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
Sarinoglu RC; Sili U; Hasdemir U; Aksu B; Soyletir G; Korten V
Curr HIV Res; 2022; 20(1):54-62. PubMed ID: 34802406
[TBL] [Abstract][Full Text] [Related]
10. Incidence of transmitted antiretroviral drug resistance in treatment-naive HIV-1-infected persons in a large South Central United States clinic.
Kleyn TJ; Liedtke MD; Harrison DL; Lockhart SM; Salvaggio MR; Ripley TL; Rathbun RC
Ann Pharmacother; 2014 Apr; 48(4):470-5. PubMed ID: 24473489
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
12. Investigation of drug resistance against protease, reverse transcriptase, and integrase inhibitors by next-generation sequencing in HIV-positive patients.
Tekin D; Gokengin D; Onay H; Erensoy S; Sertoz R
J Med Virol; 2021 Jun; 93(6):3627-3633. PubMed ID: 33026651
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan.
Tsai HC; Chen IT; Tsai KW; Lee SS; Chen YS
Infect Drug Resist; 2020; 13():4519-4529. PubMed ID: 33364799
[TBL] [Abstract][Full Text] [Related]
14. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
15. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
17. Trends in HIV-1 Drug Resistance Mutations from a U.S. Reference Laboratory from 2006 to 2017.
Kagan RM; Dunn KJ; Snell GP; Nettles RE; Kaufman HW
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):698-709. PubMed ID: 31169022
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment drug resistance in a large countrywide Ethiopian HIV-1C cohort: a comparison of Sanger and high-throughput sequencing.
Telele NF; Kalu AW; Gebre-Selassie S; Fekade D; Abdurahman S; Marrone G; Neogi U; Tegbaru B; Sönnerborg A
Sci Rep; 2018 May; 8(1):7556. PubMed ID: 29765082
[TBL] [Abstract][Full Text] [Related]
19. High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
Andersson E; Ambikan A; Brännström J; Aralaguppe SG; Yilmaz A; Albert J; Neogi U; Sönnerborg A
AIDS; 2021 Feb; 35(2):227-234. PubMed ID: 33394670
[TBL] [Abstract][Full Text] [Related]
20. Identification of minority resistance mutations in the HIV-1 integrase coding region using next generation sequencing.
Fonager J; Larsson JT; Hussing C; Neess Engsig F; Nielsen C; Fischer TK
J Clin Virol; 2015 Dec; 73():95-100. PubMed ID: 26587787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
